Patents by Inventor Alex Michael Ward

Alex Michael Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Producing Recombinant AAV
    Publication number: 20240167002
    Abstract: Provided herein are nucleic acid constructs, host insect cells, and methods for producing recombinant AAV capsids with high potency at high yield.
    Type: Application
    Filed: June 20, 2023
    Publication date: May 23, 2024
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Andrea J. Kang, Richard T. Surosky, Alex Michael Ward
  • Compositions and methods for producing recombinant AAV
    Patent number: 11718834
    Abstract: Provided herein are nucleic acid constructs, host insect cells, and methods for producing recombinant AAV capsids with high potency at high yield.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: August 8, 2023
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Andrea J. Kang, Richard T. Surosky, Alex Michael Ward
  • NOVEL COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV
    Publication number: 20230020565
    Abstract: Provided herein are nucleic acid constructs, host insect cells, and methods for producing recombinant AAV capsids with high potency at high yield.
    Type: Application
    Filed: December 4, 2020
    Publication date: January 19, 2023
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Alex Michael Ward, Hung Tran, Andrea J. Kang, Tzu-Hung Chen, Richard T. Surosky
  • CONTROLLING PHENOTYPE OF ORGANISMS WITH CRISPR/CAS GENE TARGETING
    Publication number: 20200318106
    Abstract: Engineered microbial organisms for altering gene expression are provided. In some embodiments, the engineered microbial organism comprises: one or more heterologous polynucleotide sequence comprising a phenotype coding sequence operably linked to a promoter; a heterologous polynucleotide sequence comprising an inducible promoter operably linked to a polynucleotide encoding a Cas nuclease; and a heterologous polynucleotide sequence comprising a guide RNA (gRNA) that targets the phenotype coding sequence.
    Type: Application
    Filed: December 20, 2018
    Publication date: October 8, 2020
    Inventors: Alex Michael WARD, Molly Mo-Yin LEUNG, Jean Frances SPAGNOLO-SMITH, George CHENAUX
  • COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV
    Publication number: 20200283739
    Abstract: Provided herein are nucleic acid constructs, host insect cells, and methods for producing recombinant AAV capsids with high potency at high yield.
    Type: Application
    Filed: February 14, 2020
    Publication date: September 10, 2020
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Andrea J. Kang, Richard T. Surosky, Alex Michael Ward